Meta-analysis: Enhanced liver fibrosis test to identify hepatic fibrosis in chronic liver diseases.
Alexander HinksonHannah LallyHannah GibsonRebecca JonesDenis MoirBethany ShinkinsRichard ParkerPublished in: Alimentary pharmacology & therapeutics (2023)
Meta-analysis revealed considerable variability in the ability of ELF to stage fibrosis across disease aetiologies. Research has mostly focused on viral hepatitis and NAFLD. There is currently a lack of data on the value of the ELF test in Alcohol-related liver disease and patients in primary care settings.